Disclaimer: Early release articles are not considered as final versions. Any changes will be reflected in the online version in the month the article is officially released.
Volume 32, Number 10—October 2026
Dispatch
Chlamydia psittaci Meningitis, Chile, 2023
Table
Molecular and serologic diagnostic testing results for a study of Chlamydia psittaci meningitis, Chile, 2023*
| Pathogen | Specimen | Method | Target or antibody | Result |
|---|---|---|---|---|
| Parvovirus B19 | CSF | qPCR | NS1, VP1 | Negative |
| Multiplex meningitis/encephalitis panel† | CSF | Real-time multiplex PCR assay | Pathogen-specific nucleic acid targets | Negative |
| Brucella spp. | CSF | qPCR | bcsp31, IS711 | Negative |
| Leptospira spp. | CSF | qPCR | lipL32 or 16S; specify | Negative |
| Chlamydia psittaci | CSF | qPCR | IncA and CPSIT_0607 | Positive |
| Toxoplasma gondii | CSF | qPCR | B1, REP-529 | Negative |
| Coxiella burnetii | Serum | Serology IFA | Phase I and II for IgG, IgM | Negative |
| Brucella spp. | Serum | Serology ELISA | Rose Bengal, SAT, ELISA; specify | Negative |
| Leptospira spp. | Serum | Serology ELISA | IgM | Negative |
| C. psittaci | Serum | Serology IFA | IgG, IgM | Positive IgM and IgG |
*Testing performed on CSF and serum samples for routine and zoonotic pathogens. B1, 35-fold repetitive B1 gene of Toxoplasma gondii; bcsp31, 31 kDa Brucella immunogenic protein gene; CPSIT_0607, DNA sequence gene to C. psittaci hypothetical protein; CSF, cerebral spinal fluid; IFA, indirect immunofluorescence assay; IncA, inclusion membrane protein A; IS711, insertion sequence 711 of Brucella genus; lipL32, recombinant leptospiral outer membrane protein gene; NS1, nonstructural protein 1; qPCR, quantitative PCR; REP-529, noncoding 529-bp DNA fragment that is repeated 200–300 times; SAT, standard agglutination test; VP1, viral protein 1. †Allplex Meningitis-V1 and Meningitis-V2 Assays (Seegene Inc., https://www.seegene.com).